(Gaziantep Üniversitesi, Tıp Fakültesi, Tıbbi Onkoloji Anabilim Dalı, Gaziantep, Türkiye)
(Gaziantep Üniversitesi, Tıp Fakültesi, Psikiyatri Anabilim Dalı, Gaziantep, Türkiye)
Yıl: 2020Cilt: 35Sayı: 1ISSN: 1300-7467Sayfa Aralığı: 1 - 7İngilizce

37 0
The Illness Perception and its Association with Distress in Cancer Patients Receiving Chemotherapy
OBJECTIVE Long treatment periods, repeated hospitalizations and side effects of chemotherapy besides the knowledge of having cancer may all affect the psyche of these patients. In this study, we investigated the effects of illness perception on anxiety and depression in cancer patients receiving chemotherapy treatment. METHODS A total of 182 patients were recruited in this cross-sectional study. Hospital Anxiety Depression Scale, Visual Analoge Scale and Brief Illness Perception Questionnaire were used to assess the anxiety and depression, pain and illness perception, respectively. RESULTS There were 103 (56.59%) female and 79 (43.41%) male patients in this study. The present sample had possible clinical levels of anxiety and depression of 25.3% and 26.4%, respectively, and probable clinical levels of anxiety and depression of 25.8% for both. Positive illness perception parameters, such as personal control and treatment control, were both not correlated with anxiety scores (p=0.120, p=0.070, respectively). According to the evaluation of depression scores, personel control was negatively correlated (p<0.005) and no relation was found to treatment control (p=0.062). VAS was positively correlated with negative illness perception (p<0.005). CONCLUSION Anxiety and depression were strongly associated with illness perception and pain in cancerpatients during chemotherapy treatment. Oncologists and chemotherapy nurses should pay more attentive to the signs and symptoms of anxiety and depression, and offer specific supportive therapy to each patient.
DergiAraştırma MakalesiErişime Açık
  • 1. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011;12(2):160−74.
  • 2. Smith HR. Depression in cancer patients: Pathogenesis, implications and treatment (review). Oncol Lett 2015;9(4):1509−14.
  • 3. Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry 2014;1(5):343−50.
  • 4. Linden W, Vodermaier A, Mackenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 2012;141(2-3):343−51.
  • 5. Çapar SG. Kemoterapi gören kanserli hastalarda ağrı ile anksiyete depresyon arasındaki ilişkinin değerlendirilmesi. Trakya Üniversitesi, Yüksek Lisans Tezi. 2010.
  • 6. Gray NM, Hall SJ, Browne S, Johnston M, Lee AJ, Macleod U, et al. Predictors of anxiety and depression in people with colorectal cancer. Support Care Cancer 2014;22(2):307−14.
  • 7. Buick DL. Illness representations and breast cancer: coping with radiation and chemotherapy. In: Petrie KJ, Weinman JA, eds. Perceptions of Health and Illness. Amsterdam, The Netherlands: Harwood Academic Publishers;1997. p. 379−409.
  • 8. Wilkie D, Lovejoy N, Dodd M, Tesler M. Cancer pain intensity measurement: concurrent validity of three tools-finger dynamometer, pain intensity number scale, visual analogue scale. Hosp J 1990;6(1):1−13.
  • 9. Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavia 1983;67(6):361−70.
  • 10.Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, et al. Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychol Psychother 2002;75(Pt 2):165−76.
  • 11.Aydemir Ö, Güvenir T, Küey L, Kültür S. Validity and Reliability of Turkish Version of Hospital Anxiety and Depression Scale. Turkish J Psychiatry1997;8(4):280−7.
  • 12.Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res 2006;60(6):631−7.
  • 13.Kocaman N, Özkan M, Armay Z, Özkan S. The reliability and the validity study of Turkish adaptation of the revised Illness Perception Questionnaire. Anatol J Psychiatry 2007;8(4):271−80.
  • 14.Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncologica 2001;40(2-3):282−308.
  • 15.Beser NG, Öz F. Anxiety-Depression Levels and Quality of Life of Patients with Lymphoma who are Curing Chemotherapy. J Cumhuriyet Uni Sch Nurs 2003;7:47−58.
  • 16.Alacacıoğlu A, Yavuzşen T, Diriöz M, Yeşil L, Bayrı D, Yılmaz U. Changes in Anxiety Levels Patients with Cancer Receiving Chemotherapy. UHOD 2007;2(17):87−93.
  • 17.Hong JS, Tian J. Prevalence of anxiety and depression and their risk factors in Chinese cancer patients. Support Care Cancer 2014;22(2):453−9.
  • 18.Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, et al. Health status and quality of life in patients with early-stage Hodgkin’s disease treated on southwest oncology group study 9133. J Clin Oncol 2003;21(18):3512−9.
  • 19.Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Mnogr 2004;(32):57−71.
  • 20.Somerset W, Stout SC, Miller AH, Musselman D. Breast cancer and depression. Oncology (Williston Park) 2004;18(8):1021−34.
  • 21.Kus T, Aktas G, Ekici H, Elboga G, Djamgoz S. Illness perception is a strong parameter on anxiety and depression scores in early-stage breast cancer survivors: a single-center cross-sectional study of Turkish patients. Support Care Cancer 2017;25(11):3347−55.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.